Clik here to view.
Corindus Announces Live Broadcast of Robotic-assisted PCI using CorPath® GRX...
WALTHAM, Mass. Corindus Vascular Robotics, Inc. [NYSE MKT: CVRS], a leading developer of precision vascular robotics, announced today that Fu Wai Hospital in China performed and broadcast live a PCI...
View ArticleClik here to view.
MPEG LAがCRISPR-Cas9特許の一括ライセンスでのプール化を呼び掛け
デンバー （ビジネスワイヤ） — ライセンシングの世界的リーダー企業MPEG LAは本日、CRISPR-Cas9特許の保有者に世界的なCRISPR-Cas9共同ライセンシングプラットフォーム創設への参加を呼び掛けました。本プラットフォームは、これら保有者の画期的技術への広範なアクセスを実現するためのものです。 MPEG...
View ArticleClik here to view.
Astellas Reports Full Year FY2016 Financial Results
TOKYO Astellas Pharma Inc. (TOKYO:4503)(President and CEO: Yoshihiko Hatanaka, “Astellas”) today announced the financial results for fiscal year 2016 (“FY2016”) ended March 31, 2017. “We achieved...
View ArticleClik here to view.
Dr. Reddy’s Laboratories Announces the Launch of Ezetimibe and Simvastatin...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has launched Ezetimibe and Simvastatin Tablets, 10 mg/10 mg, 10...
View ArticleClik here to view.
Corindus宣布，采用CorPath® GRX的机器人辅助PCI向韩国召开的TCT亚太峰会直播
马萨诸塞州沃尔瑟姆 — (美国商业资讯) — 精准血管机器人的领先开发者Corindus Vascular Robotics, Inc. [NYSE MKT: CVRS]今天宣布，中国阜外医院采用CorPath GRX系统实施了一台PCI手术，并向第22届TCT亚太心血管年度峰会的4,000多位与会者直播。此次年会在韩国首尔召开，吸引了来自44个国家的与会者，多数与会者来自亚太区。...
View ArticleClik here to view.
MPEG LA欢迎CRISPR-Cas9专利加入一站式许可平台
丹佛 (美国商业资讯)–技术许可领域的世界领导者MPEG LA, LLC今日宣布欢迎CRISPR-Cas9专利持有人参与全球CRISPR-Cas9联合许可平台的建立，该平台将有助于用户方便获得专利持有人的突破性技术。 MPEG LA总裁兼首席执行官Larry...
View ArticleAvita Medical CEO Shareholder Letter and Quarterly Report
VALENCIA, Calif. & PERTH, Australia & LONDON Today, the CEO of Avita Medical Limited (ASX: AVH) (OTCQX: AVMXY) issued the following letter to shareholders: Dear Shareholder, At the...
View ArticleClik here to view.
Takeda Announces FDA Accelerated Approval of ALUNBRIGTM (brigatinib)
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that ALUNBRIG™ (brigatinib) has received Accelerated Approval from the U.S. Food and Drug...
View ArticleClik here to view.
Sosei Pays GBP 35 Million for an Equity Stake and Acquisition Option...
TOKYO & LONDON Sosei Group Corporation (“Sosei”; TOKYO Mothers Index: 4565) and MiNA Therapeutics Limited (“MiNA”) announced today that the companies have entered into a definitive agreement...
View ArticleClik here to view.
康剑尼科(Congenica) B轮融资成功，投资人包括来自中国的华大基因、Healthlink Capital，以及Future Planet
剑桥，英国 世界领先的遗传病临床基因组学软件公司康剑尼科于近日宣布B轮融资成功，今日又公布了该轮融资中的第二批重要战略投资人，包括：在基因领域公认的全球领导者华大基因（BGI），专注于生命科学领域的中国风险投资机构Healthlink Capital （Healthlink）以及英国的Future Planet Capital。 华大基因与亿昊基因（Healthlink...
View ArticleClik here to view.
武田宣布ALUNBRIGTM (brigatinib)获得FDA加快核准
马萨诸塞州剑桥和日本大阪 (美国商业资讯) — 武田药品工业株式会社(TSE: 4502)今天宣布ALUNBRIG™...
View ArticleClik here to view.
GI Dynamics Announces EndoBarrier Data to be Presented at Digestive Disease Week
BOSTON & SYDNEY GI Dynamics®, Inc. (ASX:GID), a medical device company that has commercialized EndoBarrier® in Europe, the Middle East and South America for patients with type 2 diabetes and...
View ArticleClik here to view.
AVEO Reports First Quarter 2017 Financial Results and Provides Business Update
CAMBRIDGE, Mass. AVEO Oncology (NASDAQ:AVEO) today reported financial results for the first quarter ended March 31, 2017, and provided a business update. “We strengthened our balance sheet in the...
View ArticleClik here to view.
アサーシスが大量細胞融解装置ThawSTARを臨床試験で使用するためにメドシジョンと提携
米カリフォルニア州サンラファエル （ビジネスワイヤ） — 凍結細胞融解の自動化における世界的リーダー企業メドシジョンと臨床段階のバイオテクノロジー企業として専有的な細胞療法製品を開発しているアサーシスは、アサーシスの臨床試験における凍結細胞融解装置ThawSTAR®（ソースター）の使用を含め、戦略的提携関係を構築しました。 提携の第一段階として、アサーシスは6 mL AT-Closed...
View ArticleClik here to view.
Takeda Announces Publication of ALUNBRIG™ (brigatinib) Pivotal Phase 2 ALTA...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that data from the pivotal Phase 2 ALTA (ALK in Lung Cancer Trial of AP26113) clinical trial...
View ArticleClik here to view.
武田薬品がFDAからALUNBRIGTM（ブリガチニブ）の迅速承認を取得したと発表
米マサチューセッツ州ケンブリッジ & 大阪 （ビジネスワイヤ） — 武田薬品工業株式会社（TSE：...
View ArticleClik here to view.
World’s Foremost Forensic DNA Experts, Scientists and Law Enforcement to...
MADISON, Wis. Join scientists, law enforcement professionals and forensic experts from around the world to learn about the latest developments in forensic DNA research, techniques and processes at...
View ArticleClik here to view.
Pharnext Announces Strategic Partnership with Tasly, a Leading Chinese...
PARIS Regulatory News: Pharnext SA (Paris:ALPHA) (FR00111911287 – ALPHA), a biopharmaceutical company pioneering a new approach to the development of innovative drugs based on the combination and...
View ArticleClik here to view.
武田薬品: 2016年度（4-3月期）の連結業績および2017年度の連結業績予想について
大阪 （ビジネスワイヤ） — 武田薬品工業株式会社 （東証：4502）： このSmart News Release（スマート・ニュース・リリース）にはマルチメディアのコンテンツが含まれています。リリース全文はこちらから： http://www.businesswire.com/news/home/20170509006884/ja/ 2016年度も対前年で大幅な成長を達成...
View ArticleClik here to view.
Takeda Reports FY2016 Full Year Results and Issues FY2017 Guidance
OSAKA, Japan Takeda Pharmaceutical Company Limited (TOKYO:4502): Delivered substantial profit growth versus prior year Underlying Revenue grew +6.9%, with Takeda’s Growth Drivers (GI, Oncology, CNS...
View Article